IL123640A0 - Pharmaceutical combination preparations containing erythropoietin and iron preparations - Google Patents

Pharmaceutical combination preparations containing erythropoietin and iron preparations

Info

Publication number
IL123640A0
IL123640A0 IL12364096A IL12364096A IL123640A0 IL 123640 A0 IL123640 A0 IL 123640A0 IL 12364096 A IL12364096 A IL 12364096A IL 12364096 A IL12364096 A IL 12364096A IL 123640 A0 IL123640 A0 IL 123640A0
Authority
IL
Israel
Prior art keywords
preparations
pharmaceutical combination
iron
containing erythropoietin
iii
Prior art date
Application number
IL12364096A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL123640A0 publication Critical patent/IL123640A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12364096A 1995-09-14 1996-09-12 Pharmaceutical combination preparations containing erythropoietin and iron preparations IL123640A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19535571A DE19535571A1 (de) 1995-09-14 1995-09-14 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE9603997 1996-09-12

Publications (1)

Publication Number Publication Date
IL123640A0 true IL123640A0 (en) 1998-10-30

Family

ID=7773098

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12364096A IL123640A0 (en) 1995-09-14 1996-09-12 Pharmaceutical combination preparations containing erythropoietin and iron preparations
IL123640A IL123640A (en) 1995-09-14 1998-03-11 Use of recombinant human erythropoietin and iron ions in the preparation of a drug for the treatment of anemia and hemodialysis patients

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL123640A IL123640A (en) 1995-09-14 1998-03-11 Use of recombinant human erythropoietin and iron ions in the preparation of a drug for the treatment of anemia and hemodialysis patients

Country Status (26)

Country Link
US (2) US6333306B1 (et)
EP (1) EP0851762B1 (et)
JP (1) JP4783482B2 (et)
KR (1) KR100350761B1 (et)
CN (1) CN1133463C (et)
AT (1) ATE216256T1 (et)
AU (1) AU724623B2 (et)
BR (1) BR9609971A (et)
CA (1) CA2231192C (et)
CZ (1) CZ291427B6 (et)
DE (3) DE19535571A1 (et)
DK (1) DK0851762T3 (et)
EE (1) EE03856B1 (et)
ES (1) ES2174107T3 (et)
HU (1) HU225363B1 (et)
IL (2) IL123640A0 (et)
MX (1) MX9801922A (et)
NO (1) NO329908B1 (et)
NZ (1) NZ319132A (et)
PL (1) PL186776B1 (et)
PT (1) PT851762E (et)
SK (1) SK285796B6 (et)
TR (1) TR199800472T1 (et)
UA (1) UA57713C2 (et)
WO (1) WO1997009996A1 (et)
ZA (1) ZA967732B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131959A0 (en) * 1997-03-18 2001-03-19 Roche Diagnostics Gmbh Pharmaceutical combined preparations containing erythropoietin and iron preparations
EP0885613A1 (de) 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
EP1813624B1 (en) * 1998-10-23 2010-08-11 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
AU2002233230B2 (en) 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates
EP1909106B1 (en) * 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
KR20090046923A (ko) 2006-08-04 2009-05-11 프로롱 파마슈티컬스, 인크. 수식된 에리스로포이에틴
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
RS65341B1 (sr) * 2013-06-13 2024-04-30 Akebia Therapeutics Inc Kompozicije i postupci za lečenje anemije
WO2017091568A1 (en) 2015-11-23 2017-06-01 Bristol-Myers Squibb Company Additive systems for use in protein pegylation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.

Also Published As

Publication number Publication date
ATE216256T1 (de) 2002-05-15
UA57713C2 (uk) 2003-07-15
AU724623B2 (en) 2000-09-28
NO981136D0 (no) 1998-03-13
ZA967732B (en) 1998-03-13
KR19990044610A (ko) 1999-06-25
EE9800066A (et) 1998-08-17
CN1133463C (zh) 2004-01-07
HUP9900357A2 (hu) 1999-05-28
PL325640A1 (en) 1998-08-03
TR199800472T1 (xx) 1998-06-22
NO981136L (no) 1998-03-13
IL123640A (en) 2006-06-11
SK32798A3 (en) 1999-03-12
CZ291427B6 (cs) 2003-03-12
CA2231192A1 (en) 1997-03-20
JPH11512414A (ja) 1999-10-26
EP0851762A1 (de) 1998-07-08
DE19535571A1 (de) 1997-03-20
ES2174107T3 (es) 2002-11-01
US6333306B1 (en) 2001-12-25
NZ319132A (en) 1999-09-29
HUP9900357A3 (en) 2001-04-28
AU7128296A (en) 1997-04-01
CA2231192C (en) 2003-02-25
CZ72698A3 (cs) 1998-07-15
NO329908B1 (no) 2011-01-24
KR100350761B1 (ko) 2003-03-03
JP4783482B2 (ja) 2011-09-28
PT851762E (pt) 2002-08-30
BR9609971A (pt) 1999-09-14
MX9801922A (es) 1998-05-31
PL186776B1 (pl) 2004-02-27
CN1202113A (zh) 1998-12-16
SK285796B6 (sk) 2007-08-02
US20020049161A1 (en) 2002-04-25
HU225363B1 (en) 2006-10-28
DK0851762T3 (da) 2002-08-12
DE19680768D2 (de) 1998-11-05
WO1997009996A1 (de) 1997-03-20
DE59609099D1 (de) 2002-05-23
EP0851762B1 (de) 2002-04-17
EE03856B1 (et) 2002-10-15

Similar Documents

Publication Publication Date Title
IL123640A0 (en) Pharmaceutical combination preparations containing erythropoietin and iron preparations
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
HU911756D0 (en) Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases
GR3006815T3 (et)
CA2284910A1 (en) Pharmaceutical combined preparations containing erythropoietin and iron preparations
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
CA2060560A1 (en) Method for insuring adequate intracellular glutathione in tissue
HU9200438D0 (en) Process for the production of novel cumarin derivatives and their analogues preventing tumor-growth and cell-proliferation in mammals, and of medical preparations containing them
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
NZ268039A (en) Use of efaroxan in treating parkinson's disease
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
ZA9811877B (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus.
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи
HU913804D0 (en) Process for the production of medical preparations for treating arc and aids containing euphorbia hirta 1. or its parts or its extracts
UA10219A (uk) Спосіб лікування туберкульозу легень
IL98276A0 (en) Use of anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
IL101313A0 (en) Compositions and methods for increasing oxygen delivery to tissue
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: IN JOURNAL 02/2006 P. 654 PATENT APPLICATION NO. 123640 CORRECT INTERNATIONAL PUBLICATION NO. TO- WO/97/09996

FF Patent granted
KB Patent renewed